Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jun 07 | 2018CGM Swapping Supported by Senseonics/Beta Bionics PartnershipPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jun 05 | 2018FENIX Analysis: Post-AACE 2018 Device Promotional MaterialPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, SGLT2i, Topics Jun 04 | 2018FENIX Analysis: Post-AACE 2018 Drug Promotional MaterialPurchase Blast
$599
Posted in: Insulin Delivery, Topics Jun 04 | 2018Insulet Omnipod DASH Cleared by FDAPurchase Blast
$599
Posted in: SGLT2i, Topics Jun 01 | 2018FENIX Analysis: SGLT2i HF CVOTs and Stopping Early ScenariosPurchase Blast
$599
Posted in: GLP-1RA, SGLT2i, Topics May 29 | 2018Novo’s oral semaglutide beats Jardiance in PIONEER 2Purchase Blast
$599
Posted in: Glucagon, Topics May 29 | 2018Zealand completes 2nd Ph3 pivotal rescue trial for dasiglucagonPurchase Blast
$599
Posted in: Basal Insulin, Topics May 21 | 2018Beta Bionics to initiate in-home IDE for insulin-only AP systemPurchase Blast
$599
Posted in: DPP-IVi, GLP-1RA, SGLT2i, Topics May 18 | 2018AZ Q1 ‘18 Earnings UpdatesPurchase Blast
$599
Posted in: Glucagon, Insulin Delivery, Topics May 16 | 2018Zealand Q1 ‘18 Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA, Topics May 07 | 2018Thoughts on Novo PRV importance to oral semaglutidePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Insulin Delivery, Topics May 02 | 2018Novo Nordisk Q1 '18 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Topics May 02 | 2018Biocon Bangalore facility receives 7 form 483 observations from FDAPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Topics May 01 | 2018New Novo CMO?Purchase Blast
$599
Posted in: Bolus Insulin, Topics Apr 26 | 2018Adocia Partners for BioChaperone Lispro and Combo in ChinaPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Insulin Delivery, SGLT2i, Topics Apr 24 | 2018Lilly Q1 ’18 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Topics Apr 24 | 2018Sanofi’s Head of Global R&D RetiringPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
